0 0 0 0 0 0 0 0.00426004815706607
Sign Up Today X
Thanks for submitting the form.
Stockreport

Examining BioMarin Stock After Pipeline Advances and Recent Price Rebound in 2025 [Yahoo! Finance]

BioMarin Pharmaceutical Inc. (BMRN)  More Company Research Source: Yahoo! Finance
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
After a rollercoaster year, BioMarin's stock is up 4.6% this past week and 3.3% over the past month, though it's still down more than 17% for the last year. This reflects both renewed optimism and lingering caution. Much of this recent movement follows news about advances in their pipeline therapies and expanded regulatory approvals, which have reignited investor interest. Updates on key drug candidates and positive industry headlines have contributed to shifting sentiment in recent weeks. On our valuation scorecard, BioMarin earns a 4 out of 6 . This suggests it is undervalued in several key areas, yet traditional valuation methods rarely tell the whole story. Stick around as we dive into the usual approaches and reveal a smarter way to think about value at the end of the article. Find out why BioMarin Pharmaceutical's -17.3% return over the last year is lagging behind its peers. Approach 1: BioMarin Pharmaceutical Discounted Cash Flow (DCF) Analysis The Discounted Cash Fl [Read more]
IMPACT SNAPSHOT EVENT TIME: BMRN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
BMRN alerts
from News Quantified
BMRN
NEWS
BMRN
Earnings
BMRN
Analyst Actions
BMRN
SEC Filings
Stockreport

Examining BioMarin Stock After Pipeline Advances and Recent Price Rebound in 2025 [Yahoo! Finance]

BioMarin Pharmaceutical Inc.  (BMRN) 
More Company Research Source: Yahoo! Finance
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
After a rollercoaster year, BioMarin's stock is up 4.6% this past week and 3.3% over the past month, though it's still down more than 17% for the last year. This reflects both renewed optimism and lingering caution. Much of this recent movement follows news about advances in their pipeline therapies and expanded regulatory approvals, which have reignited investor interest. Updates on key drug candidates and positive industry headlines have contributed to shifting sentiment in recent weeks. On our valuation scorecard, BioMarin earns a 4 out of 6 . This suggests it is undervalued in several key areas, yet traditional valuation methods rarely tell the whole story. Stick around as we dive into the usual approaches and reveal a smarter way to think about value at the end of the article. Find out why BioMarin Pharmaceutical's -17.3% return over the last year is lagging behind its peers. Approach 1: BioMarin Pharmaceutical Discounted Cash Flow (DCF) Analysis The Discounted Cash Fl [Read more]
IMPACT SNAPSHOT
EVENT TIME:
BMRN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS